Showing 1951-1960 of 4166 results for "".
- 1-800 Contacts Enters Agreement to Acquire Vision Start-Up 6over6 Visionhttps://modernod.com/news/1-800-contacts-enters-agreement-to-acquire-vision-start-up-6over6-vision/2477177/1-800 Contacts announced that it entered into a definitive agreement to acquire 6over6 Vision (6over6), a provider of at-home vision tests using a mobile app or computer. Terms of the deal were not disclosed. 6over6 currently offers a vari
- Euclid Vision Announces Acquisition of Visionary Opticshttps://modernod.com/news/euclid-vision-announces-acquisition-of-visionary-optics/2480780/Euclid Vision, formerly Euclid Systems, has anno
- Metrovision Receives FDA Clearance for MonPackONE for Vision Electrophysiologyhttps://modernod.com/news/metrovision-receives-fda-clearance-for-monpackone-for-vision-electrophysiology/2479454/Metrovision has received FDA clearance for its MonPackONE Vision Monitor for vision electrophysiology applications, including ganzfeld flash ERG and VEP, pattern ERG and VEP, multifocal ERG and VEP, as well as sensory
- RightEye Introduces Functional Vision EyeQ Automated Testhttps://modernod.com/news/righteye-introduces-functional-vision-eyeq-automated-test/2476278/RightEye announced the launch of Functional Vision EyeQ, a first-of-its kind automated test that allows optometrists to quickly and objectively identify functional vision issues that affect a host of everyday activiti
- SightGlass Vision to Present Pivotal Clinical Trial Baseline Data Evaluating Novel Lenses to Control Nearsightedness in Childrenhttps://modernod.com/news/sightglass-vision-to-present-pivotal-clinical-trial-baseline-data-evaluating-novel-lenses-to-control-nearsightedness-in-children/2476876/SightGlass Vision announced that baseline data from CYPRESS, the company’s pivotal trial assessing the safety and efficacy of novel lenses designed to control nearsightedness in children, will be presented at the 17th International Myopia Conference 2019, held
- Vision Expo West 2020 Cancelled; Virtual Offerings Plannedhttps://modernod.com/news/vision-expo-west-2020-cancelled-new-virtual-offerings-planned/2477995/The Vision Council and Reed Exhibitions, organizers of Vision Expo, announced the decision to cancel Vision Expo West 2020, scheduled to take place in Las Vegas from September 23-26. “Over the past several months, Reed Exhibitions’ Vision Expo team and The Vision Council worked toget
- UnitedHealthcare Vision Plans Rank Highest in Customer Satisfaction in J.D. Power Reporthttps://modernod.com/news/unitedhealthcare-vision-plans-rank-highest-in-customer-satisfaction-in-j-d-power-report/2476287/UnitedHealthcare Vision plans tied for highest in customer satisfaction among the nation’s vision carriers, according to the J.D. Power 2018 Vision Plan Satisfaction Report. This marks the fifth time in 6 years that UnitedHealthcare Vision has earned the highest ranking among vision plans.
- International Sports Vision Association Launches "Ask a Sports Vision Expert" Featurehttps://modernod.com/news/international-sports-vision-association-launches-ask-a-sports-vision-expert-feature/2481622/A growing body of evidence confirms that visual abilities can be strengthened and enhanced by means of appropriate visual training. Sports vision, the science of helping athletes reach peak levels of performance through enhancement of visual skills, is becoming more important in training for all
- MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Visionhttps://modernod.com/news/metlife-to-acquire-versant-health-owner-of-davis-vision-and-superior-vision/2478292/MetLife announced it has entered into a definitive agreement to acquire Versant Health from an investor group led by Centerbridge Partners and including FFL Partners for approximately $1.675 billion in an all-cash transaction. Versant Health owns the marketplace brands Davis Vision and Superior V
- J&J Vision Presents New Data on Myopia, IOLs, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologieshttps://modernod.com/news/jj-vision-presents-new-data-on-myopia-iols-phacoemulsification-dry-eye-drops-vision-science-and-refractive-technologies-at-arvo/2480839/Johnson & Johnson Vision is presenting 26 poster and podium presentations focusing on myopia, cataract, dry eye, vision science, and refractive research at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Live and Virtual Annual Meeting. Johnson & Johnson Vision poster